Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-13-005926
Filing Date
2013-10-28
Accepted
2013-10-28 16:35:04
Documents
12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12013a1_actiniumpharma.htm S-1/A 3382126
2 OPINION OF HISCOCK & BARCLAY, LLP fs12013a1ex5i_actinium.htm EX-5.1 10023
3 EMPLOYMENT AGREEMENT, EFFECTIVE SEPTEMBER 16, 2013, BY AND BETWEEN ACTINIUM PHAR fs12013a1ex10xxxii_actinium.htm EX-10.32 40439
4 CONSENT OF GBH CPAS, PC fs12013a1ex23i_actinium.htm EX-23.1 4652
11 fs12013a1ex10xxxii_actinium0.jpg GRAPHIC 8246
12 fs12013a1ex5i_actinium0.jpg GRAPHIC 6243
  Complete submission text file 0001213900-13-005926.txt   11789932

Data Files

Seq Description Document Type Size
5 fil-20130630.xml EX-101.INS 1576926
6 fil-20130630.xsd EX-101.SCH 85613
7 fil-20130630_cal.xml EX-101.CAL 42447
8 fil-20130630_def.xml EX-101.DEF 282223
9 fil-20130630_lab.xml EX-101.LAB 606750
10 fil-20130630_pre.xml EX-101.PRE 417145
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-191468 | Film No.: 131173454
SIC: 6770 Blank Checks